- Home
- SCOR vs DYAI Comparison
SCOR vs DYAI Comparison
Compare SCOR & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCOR | DYAI |
|---|---|---|
| Founded | 1999 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 29.9M |
| IPO Year | 2007 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SCOR | DYAI |
|---|---|---|
| Price | $8.40 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 26.9K | ★ 93.5K |
| Earning Date | 03-03-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $358,940,000.00 | $3,342,195.00 |
| Revenue This Year | $2.01 | $12.52 |
| Revenue Next Year | $1.57 | $92.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $4.39 | $0.71 |
| 52 Week High | $10.18 | $1.79 |
Technical Indicators
Market Signals| Indicator | SCOR | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 76.57 | 41.99 |
| Support Level | $6.51 | $0.84 |
| Resistance Level | $8.61 | $0.99 |
| Average True Range (ATR) | 0.46 | 0.06 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 99.56 | 26.71 |
Price Performance
Historical ComparisonAbout SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.